Medtronic · Cardiovascular organic revenue growth
Will Medtronic plc report Above 8% cardiovascular organic revenue growth in fiscal 2027?
One exact rung · Fiscal 2027
This contract observes one threshold inside a recurring operating line. It does not measure the company as a whole.
The contract is one rung beneath one operating line.
S&P 500 issuerMedtronicMDT
Operating lineCardiovascular organic revenue growthmixed · % · issuer reported
Exact rungFiscal 2027 · above 8Issuer-reported result · Live and priced
Issuer-reported measure
cardiovascular organic revenue growth
Mapped directly from the dated frozen Kalshi company-KPI snapshot.
Frozen Kalshi settlement-source metadata · Sep 1, 2026 · cardiovascular organic revenue growth — captured settlement source
View metric sourceMarket measure
cardiovascular organic revenue growth
Latest listed close under the captured Kalshi rules · Aug 31, 2027, 4:00 AM UTC
View market rules